Skip to main content
. 2024 Jul 21;12(7):809. doi: 10.3390/vaccines12070809

Figure 1.

Figure 1

Participant Flow Diagram. Adapted from TIV-MNP 2015 [49] for secondary analysis. * Reactogenicity and covariate data of participants with missing immunogenicity data were included. Green boxes with bold type represent the participants included in the sample for analysis.